Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
06/20/2006 | USRE39140 pyridylmethylamines such as 1-(2-chloro-5-thiazolylmethyl)-2-cyanoiminoimidazolidine used as insecticides |
06/20/2006 | US7064207 Androgen receptor antagonists |
06/20/2006 | US7064144 Imidazole derivatives as adenosine deaminase inhibitors |
06/20/2006 | US7064142 Imidazonline compounds |
06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
06/20/2006 | US7064118 Cholinergic ligands of the nicotinic acetyl choline receptors; modulators; nervous system disordes, analgesics; smooth muscle contraction; antiinflammatory agents; drug abuse, including smoking; Alzheimer's disease; Parkinson's disease; cognition |
06/15/2006 | WO2006062984A2 Inhibitors of protein kinases |
06/15/2006 | WO2006062982A2 Urea inhibitors of map kinases |
06/15/2006 | WO2006062478A1 Novel treatment of gastrointestinal disorders |
06/15/2006 | WO2006062224A1 Carboxamide derivative |
06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
06/15/2006 | WO2006061200A1 Anthranilamide derivatives as insecticides |
06/15/2006 | WO2005113526A3 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one |
06/15/2006 | WO2005097112A3 Ion channel modulators |
06/15/2006 | US20060128966 Thia-epothilone derivatives for the treatment of cancer |
06/15/2006 | US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists |
06/15/2006 | US20060128961 Process for the production of meso-substituted cyanine dyes |
06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
06/15/2006 | US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis |
06/15/2006 | US20060128770 Thiazole derivatives |
06/15/2006 | US20060128768 Furanthiazole derivatives as heparanase inhibitors |
06/15/2006 | US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors |
06/15/2006 | US20060128754 tubulysin derivatives used as antitumor agents |
06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
06/15/2006 | US20060128747 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
06/15/2006 | US20060128722 Indoles useful in the treatment of androgen-receptor related diseases |
06/15/2006 | US20060128717 Therapeutic agents useful for treating pain |
06/15/2006 | US20060128712 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups |
06/15/2006 | US20060128706 Apoptosis promoters |
06/15/2006 | US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists |
06/15/2006 | US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
06/15/2006 | US20060128687 Lactam glycogen phosphorylase inhibitors and method of use |
06/15/2006 | US20060128685 Pyrazole derivative |
06/15/2006 | US20060128684 Anthranilic acid amide derivatives and their pharmaceutical use |
06/15/2006 | US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms |
06/15/2006 | US20060128642 Pesticides, controlling animal pests |
06/15/2006 | CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
06/15/2006 | CA2589274A1 Inhibitors of protein kinases |
06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
06/14/2006 | EP1669070A2 2-imino-thiazolidine and -oxazolidine derivatives for use as antiinflammatory agents |
06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
06/14/2006 | EP1668162A1 Detection of immobilized nucleic acid |
06/14/2006 | EP1668008A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
06/14/2006 | EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors |
06/14/2006 | EP1668005A1 Acyloxymethylcarbamate prodrugs of oxazolidinones |
06/14/2006 | EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof |
06/14/2006 | EP1667995A1 Benzimidazole acetonitriles |
06/14/2006 | EP1667994A1 Quinolone antibacterial agents |
06/14/2006 | EP1667993A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
06/14/2006 | EP1667984A1 Gamma-secretase inhibitors |
06/14/2006 | EP1667981A1 Isoquinoline potassium channel inhibitors |
06/14/2006 | EP1667980A1 1,4-disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
06/14/2006 | EP1667977A1 Isoquinolinone potassium channel inhibitors |
06/14/2006 | EP1667970A1 Heterocyclic- or aryloxy, -thio 0r -amino substituted indoles-2-carboxylic acids or esters as pai-1 inhibitors |
06/14/2006 | EP1667643A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
06/14/2006 | EP1446404B1 Rosiglitazone edisylates and their use as antidiabetics |
06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
06/14/2006 | CN1788000A Phthalazinone derivatives |
06/14/2006 | CN1787998A Method for producing bipyridinium compound |
06/14/2006 | CN1787997A 4-arylsulphonylpiperidine derivatives for antagonism of the 5-HT2A receptor |
06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
06/14/2006 | CN1785983A Benzo [1,2,3] thiadiazole derivative its synthesis method and use |
06/14/2006 | CN1259318C Tetrazoyl oxime derivative and agrochemical containing the same as active ingredient |
06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
06/13/2006 | USRE39131 Heterocyclic compounds |
06/13/2006 | USRE39130 iNSECTICIDES; CONTAINING A 2-CYANOIMINO GROUP ON HETEROCYCLIC RING |
06/13/2006 | USRE39129 Insecticides; containing a 2-cyanoimino group attached to heterocyclic ring |
06/13/2006 | USRE39127 Heterocyclic compounds |
06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
06/13/2006 | US7060834 Using a 2-aminoquinoline compound |
06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
06/13/2006 | US7060722 Proline derivatives and use thereof as drugs |
06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
06/13/2006 | CA2249562C Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
06/13/2006 | CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same |
06/13/2006 | CA2158981C Herbicidal heterocyclic-substituted pyridines |
06/08/2006 | WO2006060424A2 Inducible nitric oxide synthase dimerization inhibitors |
06/08/2006 | WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
06/08/2006 | WO2006058720A2 Novel compounds for the treatment of neurological disorders |
06/08/2006 | WO2006058630A1 Cyclic iminocarbamates and use thereof |
06/08/2006 | US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems |
06/08/2006 | US20060122432 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol |
06/08/2006 | US20060122399 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
06/08/2006 | US20060122397 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor; neurological disorders, psychiatric disorders, acute and chronic pain |
06/08/2006 | US20060122387 Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
06/08/2006 | US20060122241 Novel macrocycles for the treatment of cancer diseases |
06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
06/08/2006 | US20060122229 4,5-diarylthiazole derivatives as cb-1 ligands |